您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > BW 373U86
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
BW 373U86
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
BW 373U86图片
CAS NO:155836-50-3
包装:10mg
规格:98%
市场价:4592元
分子量:435.61

产品介绍
Non-peptide delta agonist,potent and selective
CAS:155836-50-3
分子式:C27H37N3O2
分子量:435.61
纯度:98%
存储:Store at -20°C

Background:

Ki: 1.8, 15, 85 and 34 nM for delta, mu, epsilon and kappa receptor


Opioid receptors are heterogeneous and at least four types, mu,.delta, kappa and epsilon, are known to exist. Currently, all clinically used opiates act through the mu receptor to induce analgesia; however, they also induce unwanted side effects such as respiratory depression, dependence, constipation and muscle rigidity.BW 373U86 is a novel, potent and selective nonpeptidic delta opioid receptor agonist.


In vitro: BW 373U86 was a potent delta receptor-selective ligand in receptor binding assays. The Ki values were 1 .8 ± 0.4, 15 ± 3, 85 ± 4 and 34 ± 3 nM for delta, mu, epsilon and kappa receptor binding sites, respectively. BW 373U86 inhibited electncally evoked muscle contraction of mouse vas deferens with an ED50 value of 0.2 ± 0.06 nM [1].


In vivo: BW 373U86 inhibited the acoustic startle reflex after subcutaneous administration from 0.2- to 2-mg/kg doses in rats, and this inhibition was blocked by naltnndole. BW 373U86 also induced a dose-dependent increase of locomotor activity in rats at similar doses. This effect was inhibited by naltnndole [3].


Clinical trial: Up to now, BW 373U86 is still in the preclinical development stage.


Reference:
[1] Chang KJ, Rigdon GC, Howard JL, McNutt RW.  A novel, potent and selective nonpeptidic delta opioid receptor agonist BW 373U86. J Pharmacol Exp Ther. 1993 Nov;267(2):852-7.